Outcomes of endoscopic transcanal type 1 cartilage tympanoplasty.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 13 07 2019
accepted: 04 09 2019
pubmed: 15 9 2019
medline: 13 5 2020
entrez: 15 9 2019
Statut: ppublish

Résumé

We aimed to evaluate air-bone GAP (ABG), graft success and hearing gain according to the size and location of perforation in patients who underwent endoscopic transcanal type 1 cartilage tympanoplasty due to the tympanic membrane perforation and chronic otitis media. The 104 patients (52 male and 52 female) who underwent endoscopic transcanal type 1 cartilage tympanoplasty, were evaluated retrospectively. Tragal cartilage grafts were utilized in all patients. Perforation size/location, duration of surgery, pre-operative and post-operative (6th month) average ABG, and pure-tone audiometric results (at 500-1000-2000-4000 Hz) as well as overall graft success were evaluated. The mean duration of surgery was 45.60 ± 17.39 min. Perforations were most frequently located in anterior quadrant with moderate sized. The post-operative air-conduction results were significantly improved at 500-1000-2000-4000 Hz frequencies. Similarly, pre-operative air-conduction pure-tone average (PTA) (35.36 ± 11.9 dB) was significantly decreased (22.34 ± 7.9 dB) after postoperative 6 months (p ≤ 0.001). The overall graft success rate was 93.2%. Moreover, pre-operative mean ABG (19.82 ± 7.4 dB) was significantly decreased (9.05 ± 4.3 dB) after postoperative 6 months (p ≤ 0.001). Endoscopic transcanal type 1 cartilage tympanoplasty achieved a high graft success rate, and improved hearing results, regardless of the perforations' location and size. Endoscopic tympanoplasty provides high patient safety and comfort in middle-ear surgery by wide visualization, easy applicability, short-operation duration, low complication risk, and less invasive approach.

Identifiants

pubmed: 31520162
doi: 10.1007/s00405-019-05636-w
pii: 10.1007/s00405-019-05636-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3295-3299

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Braz J Otorhinolaryngol. 2016 May-Jun;82(3):321-5
pubmed: 26642752
Clin Exp Otorhinolaryngol. 2018 Mar;11(1):23-29
pubmed: 28797141
Otol Neurotol. 2016 Aug;37(7):838-46
pubmed: 27273405
JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1088-1093
pubmed: 27540858
Auris Nasus Larynx. 2015 Feb;42(1):20-3
pubmed: 25183404
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):853-60
pubmed: 22639200
Int J Pediatr Otorhinolaryngol. 2014 Jul;78(7):1084-9
pubmed: 24816224
Otolaryngol Head Neck Surg. 2017 Oct;157(4):683-689
pubmed: 28585463
Clin Exp Otorhinolaryngol. 2017 Mar;10(1):44-49
pubmed: 27334511
Laryngoscope. 2016 Aug;126(8):1893-8
pubmed: 26535476
Int J Pediatr Otorhinolaryngol. 2015 Nov;79(11):1860-4
pubmed: 26337560

Auteurs

Doğukan Özdemir (D)

Department of Otorhinolaryngology, University of Health Sciences, Samsun, Turkey. drdogukan@hotmail.com.
Department of Otorhinolaryngology, Samsun Training and Research Hospital, Samsun, Turkey. drdogukan@hotmail.com.

Abdulkadir Özgür (A)

Department of Otorhinolaryngology, University of Health Sciences, Samsun, Turkey.

Gökhan Akgül (G)

Department of Otorhinolaryngology, Samsun Training and Research Hospital, Samsun, Turkey.

Mehmet Çelebi (M)

Department of Otorhinolaryngology, Samsun Training and Research Hospital, Samsun, Turkey.

Dursun Mehmet Mehel (DM)

Department of Otorhinolaryngology, University of Health Sciences, Samsun, Turkey.

Tuğba Yemiş (T)

Department of Otorhinolaryngology, Samsun Training and Research Hospital, Samsun, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH